U.S. Banks Stock News

Fastenal (FAST) just wrapped up FY 2025 with fourth quarter revenue of US$2.0b and EPS of US$0.26, capping a trailing twelve month run that produced US$8.2b in revenue and EPS of US$1.10. Over the past year, the company has seen revenue move from US$7.5b to US$8.2b and EPS edge from about US$1.00 to US$1.10, while net income on a trailing basis has tracked around US$1.2b. With net profit margins holding in the mid-teens, investors now have a clearer view of how consistent profitability and...

Comerica (CMA) just wrapped up FY 2025 with fourth quarter revenue of US$836 million and basic EPS of US$1.28, supported by trailing twelve month revenue of US$3.27 billion and EPS of US$5.33. Over recent periods, the bank has seen revenue move from US$3.20 billion and EPS of US$5.05 in the twelve months to Q4 2024 to US$3.27 billion and EPS of US$5.33 in the latest twelve month stretch, giving investors a clearer read on how earnings and top line are tracking together. With a trailing net...

Earlier this month, Calumet, Inc. announced that Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. completed an upsized private placement of US$405 million in 9.75% Senior Notes due 2031 under Rule 144A and Regulation S, issuing the notes at 98.996% of par for net proceeds of about US$393 million. The company plans to use the proceeds, alongside cash on hand and its revolving credit facility, to redeem its higher-coupon 11.00% 2026 and 8.125% 2027 senior notes, potentially...

F.N.B (FNB) is back in the spotlight today as the regional bank prepares to report quarterly earnings, with investors focused on whether its recent revenue momentum and steady analyst expectations hold up. See our latest analysis for F.N.B. At a share price of $17.27, F.N.B has seen a 12.8% 90 day share price return and an 11.9% 1 year total shareholder return, suggesting momentum has been building ahead of the upcoming earnings update and recent analyst coverage. If F.N.B’s setup has your...

Forestar Group (FOR) opened fiscal 2026 with Q1 revenue of US$273 million and basic EPS of US$0.30, setting a measured tone after a very strong finish to 2025. The company has seen quarterly revenue move from US$250.4 million in Q1 2025 to US$551.4 million in Q4 2024 and then US$670.5 million in Q4 2025. Over the same periods, basic EPS ran from US$0.32 to US$1.61 and then US$1.71, so the latest print lands against a backdrop of high recent throughput and puts the focus firmly on how margins...

Richtech Robotics FY 2025 Earnings Snapshot Richtech Robotics (RR) closed FY 2025 with Q4 revenue of US$1.4 million and a basic EPS loss of US$0.02, as net income excluding extra items came in at a loss of US$3.6 million. This result sets the stage for another year of rebuilding the path toward profitability. The company reported quarterly revenue moving from US$1.3 million in Q1 2025 to US$1.4 million in Q4 2025, while basic EPS ranged between a loss of US$0.04 and a loss of US$0.02 across...

Wondering if Kaspi.kz at US$77.40 is offering real value or just headline noise? This article walks through what the current price could mean for you as an investor. The share price closed at US$77.40, with a 1.3% decline over the last 7 days, a 0.2% decline over the last 30 days, a 0.2% decline year to date, a 19.0% decline over 1 year, and returns of 17.8% over 3 years and 53.6% over 5 years. Recent coverage of Kaspi.kz has focused on how the business fits into the broader fintech and...

U.S. Bancorp (USB) just posted another solid update, with third quarter FY 2025 revenue at US$6.7b and EPS at US$1.22, giving investors a clear look at the bank's current earnings power. Over recent quarters, revenue has moved from US$6.3b in Q3 FY 2024 to US$6.4b in Q4 FY 2024 and then to US$6.7b in Q3 FY 2025, while quarterly EPS has ranged from about US$1.01 to US$1.22 across that same stretch. With net income holding in the US$1.6b to US$1.9b range and profitability supported by metrics...

KeyCorp (KEY) just posted another solid quarter, with Q3 FY 2025 revenue at US$1,779 million and basic EPS of US$0.41, while trailing twelve month revenue sat at US$5,934 million and EPS at US$0.87. Over the past few reporting periods, revenue has moved from US$816 million in Q4 2024 to US$1,646 million in Q1 2025, US$1,693 million in Q2 2025 and now US$1,779 million in Q3 2025. Quarterly EPS has shifted from a loss of US$0.28 in Q4 2024 to US$0.34, US$0.35 and US$0.41 respectively. With that...

Ascendis Pharma (NasdaqGS:ASND) reported positive topline Week 52 results from its COACH Phase 2 trial in children with achondroplasia. The combination therapy showed durable growth, improved body proportionality, and a favorable safety profile over the 52 week period. The data support the company’s achondroplasia program as a potential backbone treatment approach for pediatric patients. Ascendis Pharma, a biopharmaceutical company focused on endocrinology related rare diseases, is...

Peoples Bancorp (PEBO) has put up a solid set of headline numbers for FY 2025 Q3, with total revenue of US$107.9 million, basic EPS of US$0.83 and net income of US$29.2 million, while its net profit margin over the last twelve months sits at 18.2% compared with 24.6% a year earlier. Over recent quarters the company has seen revenue move from US$106.97 million in FY 2024 Q3 to US$97.82 million in FY 2025 Q2 and then to US$107.9 million in FY 2025 Q3, alongside quarterly EPS prints of US$0.90,...

Mercantile Bank (MBWM) just posted its FY 2025 third quarter numbers with total revenue of US$62.2 million and basic EPS of US$1.46, alongside net income, excluding extra items, of US$23.8 million, giving investors a clean read on core profitability. The bank has seen revenue move from US$56.9 million in Q3 2024 to US$62.2 million in Q3 2025, while quarterly EPS has shifted from about US$1.22 to US$1.46 over the same period. Trailing twelve month EPS is roughly US$5.28, and investors are...

In January 2026, Castle Biosciences reported that 2025 total revenue is expected to exceed US$340 million, above its prior US$327–US$335 million range, alongside strong year-on-year growth in test volumes for its core DecisionDx-Melanoma and TissueCypher Barrett’s Esophagus assays. The sharp increase in core test reports, particularly for TissueCypher, suggests that Castle’s efforts to broaden clinical adoption and utilization are gaining traction across its key diagnostic franchises. Now...

It's not a stretch to say that Kingsoft Cloud Holdings Limited's ( NASDAQ:KC ) price-to-sales (or "P/S") ratio of 2.8x...

The market was pleased with the recent earnings report from The Simply Good Foods Company ( NASDAQ:SMPL ), despite the...

Key Insights Scotts Miracle-Gro's Annual General Meeting to take place on 26th of January Total pay for CEO Jim...

Recent developments in the U.S. stock market have been marked by volatility, with major indices such as the Dow Jones and S&P 500 experiencing declines amid geopolitical tensions and rising bond yields. In this environment, investors often seek opportunities in undervalued stocks that may be trading at significant discounts, offering potential for growth when market conditions stabilize.

As the U.S. stock market faces turbulence with major indices like the Dow Jones and S&P 500 experiencing declines due to geopolitical tensions, investors are increasingly turning their attention to growth companies with strong insider ownership. In such uncertain times, these firms can offer a unique appeal, as high insider ownership often signals confidence from those who know the company best and may provide stability amid broader market volatility.

The U.S. stock market has recently been rattled by geopolitical tensions, with major indices experiencing declines amid tariff threats and surging bond yields. In such a volatile landscape, investors often turn their attention to smaller companies that might offer unique opportunities. Penny stocks, despite the outdated term, remain relevant as they represent smaller or newer firms that can provide significant value when backed by strong financials. This article highlights three penny stocks...

As the U.S. market grapples with geopolitical tensions and fluctuating bond yields, small-cap stocks in the S&P 600 have shown resilience amid broader market volatility. With major indices like the Dow Jones and Nasdaq experiencing declines due to tariff threats, investors are increasingly turning their attention to lesser-known opportunities that may offer growth potential in uncertain times. In this context, identifying a good stock often involves looking for companies with strong...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Sensient Technologies Corporation ( NYSE:SXT ) shareholders may have reason to be concerned, as several insiders sold...

Insiders who bought US$2.15m worth of AlphaTON Capital Corp.'s ( NASDAQ:ATON ) stock at an average buy price of US$4.10...

As U.S. markets experience weekly losses amid rising Treasury yields and economic uncertainty, investors are increasingly on the lookout for stocks that may be undervalued relative to their intrinsic worth. In this environment, identifying companies like Arthur J. Gallagher and others that could be priced below their estimated value can offer potential opportunities for those looking to navigate the current financial landscape effectively.